Ventas Inc. ($VTR) Stock Forecast: Down 2.4% Today

What is Ventas Inc.?

Ventas, Inc. (VTR) Bearish Movement: Ventas, Inc. (VTR) is a real estate investment trust specializing in senior housing and healthcare properties. The market for VTR witnessed a significant bearish movement recently.

Why is Ventas Inc. going down?

VTR stock is down 2.4% on Mar 5, 2026 16:36

• A notable investment firm increased its stake in VTR despite recent insider selling and a quarterly EPS miss, potentially causing concern among investors and contributing to the bearish trend.
• Positive predictions and an upwardly adjusted price target for VTR from another firm were not sufficient to counterbalance the impact of insider sales and the earnings miss, resulting in a decline in the stock price.
• Despite a presentation at a conference highlighting strategic growth in senior housing, investors may not have been convinced of immediate positive outcomes, further adding to the bearish sentiment.
• The conflicting signals from analysts, including a "Moderate Buy" rating and varying price predictions, combined with insider sales and the earnings miss likely played a role in the bearish movement observed in VTR recently.

VTR Price Chart

VTR Technical Analysis

VTR News

Dimensional Fund Advisors LP Buys 160,998 Shares of Ventas, Inc. $VTR

Dimensional Fund Advisors LP significantly increased its stake in Ventas, Inc. (NYSE:VTR) by purchasing 160,998 shares, bringing its total holdings to 6,601,143 shares valued at approximately $462 million. This comes despite recent insider selling by Ventas executives and a quarterly EPS miss. Analysts, however, maintain a "Moderate Buy" rating for Ventas with an average price target of $89, and the company recently increased its quarterly dividend.

https://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-buys-160998-shares-of-ventas-inc-vtr-2026-03-05/

Assessing Welltower (WELL) Valuation After Strong Senior Housing Earnings And Bullish Analyst Outlook

Welltower (WELL) has seen renewed investor attention following strong Q4 FY2025 earnings, reporting 9.6% same-store revenue growth and improved senior housing metrics. While the company has shown significant share price momentum, analysts are divided on its valuation, with a "most popular narrative" suggesting 5.5% undervaluation based on future growth expectations, contrasting with concerns about its rich sales multiple compared to the sector average. Investors are encouraged to consider a balanced view of both growth prospects and potential risks like inflation and high sales valuation.

https://simplywall.st/stocks/us/real-estate/nyse-well/welltower/news/assessing-welltower-well-valuation-after-strong-senior-housi

Ventas at Raymond James Conference: Strategic Growth in Senior Housing

Ventas Inc. presented at the 47th Annual Raymond James Institutional Investor Conference, detailing its strategic focus on senior housing. The company is leveraging demographic trends, aiming for double-digit NOI growth, and has invested over $5 billion in the sector. Ventas highlighted its Operational Insights platform and aggressive acquisition strategy to drive future growth and shareholder value.

https://m.investing.com/news/transcripts/ventas-at-raymond-james-conference-strategic-growth-in-senior-housing-93CH-4541790?ampMode=1

The Bull Case For Healthcare Realty Trust (HR) Could Change Following Deloitte Auditor Switch And 2026 Guidance

Healthcare Realty Trust (HR) has switched its auditor from BDO USA to Deloitte & Touche LLP, a move that follows the company's recent announcement of a stronger balance sheet and detailed 2026 financial guidance. This change intensifies focus on financial reporting quality and oversight, as the company aims to convert current under-earning assets into future cash flow within its outpatient medical building portfolio. Despite projected balance sheet improvements, potential risks remain with high leverage if operational gains do not meet the targeted net operating income uplift.

https://simplywall.st/stocks/us/real-estate/nyse-hr/healthcare-realty-trust/news/the-bull-case-for-healthcare-realty-trust-hr-could-change-fo-1

Mizuho Forecasts Strong Price Appreciation for Ventas (NYSE:VTR) Stock

Mizuho has increased its price target for Ventas (NYSE:VTR) from $87.00 to $94.00, reiterating an "outperform" rating and suggesting an 8.76% upside. Other analysts have also issued positive reports, contributing to a "Moderate Buy" average rating for the real estate investment trust. Despite a current trading price of $86.43 and a reported earnings miss, institutional investors show increased interest, and insider sales have been noted.

https://www.marketbeat.com/instant-alerts/mizuho-forecasts-strong-price-appreciation-for-ventas-nysevtr-stock-2026-03-04/

Trending Today

Ethereum ($ETH) Crypto Forecast: Down 5.5% Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.3% Today

Ventas Inc. Price History

09.11.2025 - VTR Stock was down 1.1%

• VTR witnessed a significant decline in its stock value today.
• Despite insider selling activities, prominent institutional investors such as Investment Management Corp of Ontario and Natixis have been increasing their holdings in VTR, while California Public Employees Retirement System has been decreasing its position.
• The surge in VTR's stock price to an all-time high was driven by robust Q3 2025 earnings, a successful senior notes offering, and favorable analyst evaluations.
• The downtrend in VTR's stock today may be due to some investors engaging in profit-taking following the recent peak, disregarding the positive developments and analyst endorsements related to Ventas, Inc.

30.09.2025 - VTR Stock was up 5.2%

• VTR experienced a strong bullish movement today following its Q3 earnings report.
• The company surpassed FFO and revenue estimates, indicating solid financial performance.
• Positive operating trends in its senior housing and medical office properties likely contributed to the strong results.
• Despite potential challenges like high interest expenses, VTR's well-diversified tenant base and strong portfolio performance seem to have buoyed investor confidence, driving the bullish market movement.

01.04.2025 - VTR Stock was down 5.3%

• VTR had a bearish movement today despite reporting strong Q1 results with FFO and revenues exceeding estimates.
• The market may have reacted negatively due to concerns over high interest expenses. These expenses could have overshadowed the positive same-store cash NOI growth driven by SHOP occupancy.
• Investors might be cautious about the impact of these expenses on VTR's future earnings and overall financial health, leading to the bearish trend in the stock price today.

01.04.2025 - VTR Stock was down 5.3%

• Speculations about high interest expenses impacting VTR's Q1 earnings could be a reason for its bearish movement today, despite positive operating trends.
• Examination of performance metrics beyond analyst estimates may have uncovered weaker performance indicators, leading to a pessimistic market outlook on VTR.
• Investor disappointment in VTR's performance compared to peers like Healthpeak (DOC), whose strong Q1 results showcased the strength of their portfolios, might have contributed to the negative sentiment.
• Uncertainties surrounding VTR's viability as a dividend stock could have lead to investor concern, as doubts about the company's capacity to sustain dividend payments have adversely affected its stock price.

30.09.2025 - VTR Stock was up 7.4%

• VTR experienced a strong bullish movement today following its Q3 earnings report.
• The company beat estimates for FFO and revenues, driven by gains in senior housing and outpatient medical portfolios.
• Positive operating trends in senior housing and a well-diversified tenant base likely contributed to the strong performance.
• The market reacted positively to the results, indicating investor confidence in VTR's ability to navigate challenges such as high interest expenses.

05.00.2026 - VTR Stock was down 0.7%

• Today's downward movement in VTR may be due to short-term traders taking profits in response to negative near-term sentiment.
• Investor focus on Ventas' tangible book value per share could have influenced perceptions and led to some selling activity.
• Comparisons with Universal Health Realty (UHT) as a strong dividend contender within the healthcare REIT sector might have diverted attention away from VTR temporarily.
• Despite the recent bearish trend, VTR's strategic positioning in defensive market sectors and growth potential make it an appealing choice for investors seeking stability and passive income.

09.03.2025 - VTR Stock was down 5.5%

• The bearish movement seen in VTR today might be linked to profit-taking by investors following a period of strong performance.
• While the long-term outlook remains positive with increasing healthcare spending and an aging population, short-term worries such as competition and tenant concentration risks could be influencing the recent decline.
• Investors seem to be reassessing their positions in VTR amid current market conditions and uncertainties in the healthcare industry.
• References to VTR as a high dividend stock and its resilience in challenging circumstances may offer some comfort to investors, but there appears to have been a shift in market sentiment today.

04.03.2025 - VTR Stock was down 5.3%

• Despite positive long-term prospects for Ventas due to rising healthcare expenditures and an aging population, the stock experienced a bearish movement today.
• The bearish movement could be attributed to short-term market fluctuations or profit-taking by investors.
• Investors may have reacted to broader market conditions or specific industry news impacting sentiment towards VTR, overshadowing its strong fundamentals in the near term.

05.02.2026 - VTR Stock was down 2.4%

• A notable investment firm increased its stake in VTR despite recent insider selling and a quarterly EPS miss, potentially causing concern among investors and contributing to the bearish trend.
• Positive predictions and an upwardly adjusted price target for VTR from another firm were not sufficient to counterbalance the impact of insider sales and the earnings miss, resulting in a decline in the stock price.
• Despite a presentation at a conference highlighting strategic growth in senior housing, investors may not have been convinced of immediate positive outcomes, further adding to the bearish sentiment.
• The conflicting signals from analysts, including a "Moderate Buy" rating and varying price predictions, combined with insider sales and the earnings miss likely played a role in the bearish movement observed in VTR recently.

13.01.2025 - VTR Stock was up 7.6%

• Q4 results from VTR surpassed revenue and FFO estimates, attributed to SHOP same-store average occupancy growth leading to an increase in same-store cash NOI.
• The impressive Q4 FFO and revenue outcomes hint at VTR's strong operational performance and growth opportunities.
• Positive investor reactions to the better-than-expected financial results reflect confidence in VTR's capabilities in the healthcare real estate market.
• By emphasizing key metrics alongside top and bottom-line figures, investors gained a deeper insight into VTR's performance, contributing to the stock's bullish trend.

13.01.2025 - VTR Stock was up 5.3%

• Ventas (VTR) exceeded expectations for Q4 FFO and revenue, surpassing estimates by 1.25% and 2.23% respectively.
• The company's strong financial performance and growth potential were highlighted by the positive earnings surprise.
• Share prices rose, reflecting investors' optimistic response and their expectation of sustained success and profitability in healthcare real estate.
• The increase in market activity may stem from heightened investor confidence in Ventas (VTR) due to its robust financial results and outlook.

10.11.2025 - VTR Stock was down 2.1%

• Factors contributing to the bearish movement in Ventas, Inc. ($VTR) stock today include:
• Recent insider selling by key company executives, like the CEO and CFO, despite the company's strong financial performance and record-high stock price, raising investor apprehensions about its future prospects.
• Increased institutional ownership by Investment Management Corp of Ontario and Natixis, potentially prompting profit-taking from other institutional investors such as the California Public Employees Retirement System, resulting in a downward shift in the stock price.
• Investor uncertainty and profit-taking possibly stemming from the elevated P/E ratio of Ventas stock, recent senior notes offering, and executive retirement, contributing to the current bearish sentiment in the market.
• Analysts upholding a "Moderate Buy" rating with a target price range of $75 to $91, reflecting mixed market sentiments that could exacerbate the volatility and downtrend in Ventas stock.